These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 6894195

  • 21. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
    Martin-Malo A, Rodriguez M, Martinez ME, Torres A, Felsenfeld AJ.
    Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
    [Abstract] [Full Text] [Related]

  • 22. Parathyroid morphology in suppressible and nonsuppressible renal hyperparathyroidism.
    Black WC, Slatopolsky E, Elkan I, Hoffsten P.
    Lab Invest; 1970 Nov; 23(5):497-509. PubMed ID: 5483883
    [No Abstract] [Full Text] [Related]

  • 23. Calcium and phosphorus metabolism and bone disease in uremia.
    Kleeman CR, Massry SG, Coburn JW, Popovtzer MM.
    Clin Orthop Relat Res; 1970 Nov; 68():210-37. PubMed ID: 4905786
    [No Abstract] [Full Text] [Related]

  • 24. Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction.
    Lafage-Proust MH, Combe C, Barthe N, Aparicio M.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):512-9. PubMed ID: 10022409
    [Abstract] [Full Text] [Related]

  • 25. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion.
    Galitzer H, Ben-Dov I, Lavi-Moshayoff V, Naveh-Many T, Silver J.
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):363-7. PubMed ID: 18660671
    [Abstract] [Full Text] [Related]

  • 26. Parathyroid growth and suppression in renal failure.
    Lewin E, Huan J, Olgaard K.
    Semin Dial; 2006 Jul; 19(3):238-45. PubMed ID: 16689976
    [Abstract] [Full Text] [Related]

  • 27. On the pathogenesis of the uremic state--an exposition of the trade-off hypothesis.
    Bricker NS.
    Nihon Jinzo Gakkai Shi; 1974 Apr; 16(4):327-39. PubMed ID: 4474520
    [No Abstract] [Full Text] [Related]

  • 28. In vitro studies of normal and abnormal parathyroid tissue.
    Sherwood LM, Herrmann I, Bassett CA.
    Arch Intern Med; 1969 Oct; 124(4):426-30. PubMed ID: 5823014
    [No Abstract] [Full Text] [Related]

  • 29. Effect of 24,25-dihydroxycholecalciferol on intestinal absorption of calcium and phosphate and on parathyroid hormone secretion in chronic renal failure.
    Varghese Z, Moorhead JF, Farrington K.
    Nephron; 1992 Oct; 60(3):286-91. PubMed ID: 1565181
    [Abstract] [Full Text] [Related]

  • 30. "Magnification phenomenon" in chronic renal disease.
    Bricker NS, Fine LG, Kaplan M, Epstein M, Bourgoignie JJ, Light A.
    N Engl J Med; 1978 Dec 07; 299(23):1287-93. PubMed ID: 714096
    [No Abstract] [Full Text] [Related]

  • 31. On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".
    Bricker NS.
    N Engl J Med; 1972 May 18; 286(20):1093-9. PubMed ID: 4553202
    [No Abstract] [Full Text] [Related]

  • 32. The parathyroid-bone axis in uremia: new insights into old questions.
    Hory B, Drüeke TB.
    Curr Opin Nephrol Hypertens; 1997 Jan 18; 6(1):40-8. PubMed ID: 9051353
    [Abstract] [Full Text] [Related]

  • 33. Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites.
    Somerville PJ, Kaye M.
    Kidney Int; 1978 Sep 18; 14(3):245-54. PubMed ID: 723151
    [Abstract] [Full Text] [Related]

  • 34. High-phosphorus diet maximizes and low-dose calcitriol attenuates skeletal muscle changes in long-term uremic rats.
    Acevedo LM, López I, Peralta-Ramírez A, Pineda C, Chamizo VE, Rodríguez M, Aguilera-Tejero E, Rivero JL.
    J Appl Physiol (1985); 2016 May 01; 120(9):1059-69. PubMed ID: 26869708
    [Abstract] [Full Text] [Related]

  • 35. Parathyroid function in uremic children with and without osteodystrophy.
    Roof BS, Piel CF, Rames L, Potter D, Gordan GS.
    Pediatrics; 1974 Mar 01; 53(3):404-9. PubMed ID: 4815261
    [No Abstract] [Full Text] [Related]

  • 36. Pathogenesis of renal osteodystrophy: roles of phosphate and skeletal resistance to PTH.
    Ritz E, Malluche HH, Krempien B, Tschope W, Massry SG.
    Adv Exp Med Biol; 1978 Mar 01; 103():423-36. PubMed ID: 362849
    [No Abstract] [Full Text] [Related]

  • 37. [Osteodystrophy in patients with chronic kidney insufficiency].
    Ermolenko VM, Nikiforsva NV.
    Urol Nefrol (Mosk); 1970 Mar 01; 35(5):57-63. PubMed ID: 4929738
    [No Abstract] [Full Text] [Related]

  • 38. Divalent ion metabolism and osteodystrophy in chronic renal failure.
    Kleeman CR, Better O, Massry SG, Maxwell MH.
    Yale J Biol Med; 1967 Aug 01; 40(1):1-45. PubMed ID: 6056189
    [No Abstract] [Full Text] [Related]

  • 39. 24,25(OH)2D3 enhances the calcemic effect of 1,25(OH)2D3 in PTX rats.
    Wald H, Traves J, Popovtzer MM.
    Proc Soc Exp Biol Med; 1987 Jan 01; 184(1):47-9. PubMed ID: 3491995
    [Abstract] [Full Text] [Related]

  • 40. Bone formation and resorption in tissue culture. Effect of agents implicated in renal osteodystrophy.
    Raisz LG.
    Arch Intern Med; 1970 Nov 01; 126(5):887-90. PubMed ID: 4319935
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.